Skip to main content
Clinical Trials/JPRN-UMIN000013941
JPRN-UMIN000013941
Recruiting
Phase 2

ovel Regenerative Therapy with Autologus Myoblast Sheet for Pediatric Heart Failure patients - Novel Regenerative Therapy with Autologus Myoblast Sheet for Pediatric Heart Failure patients

Department of Cardiovascular Surgery, Graduate School of medicine, Osaka University0 sites15 target enrollmentMay 13, 2014

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Severe Cardiomyopathy in Pediatric patietns
Sponsor
Department of Cardiovascular Surgery, Graduate School of medicine, Osaka University
Enrollment
15
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 13, 2014
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Department of Cardiovascular Surgery, Graduate School of medicine, Osaka University

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Patients who have the foillowings. 1\)any degenerative muscle diseases. 2\)active infection. 3\)suffered from any malignant diseases within 5 years 4\)infected by HIV, HBV, HCV or HTLV 5\)functional single ventricle physiology 6\)restrictive cardiomyopathy 7\)irreversible hepatic or renal dysfuntion 8\)severe mental retardation or chromosomal abnormality 9\)severe pulmonary hyper tension

Outcomes

Primary Outcomes

Not specified

Similar Trials